 | • レポートコード：QFJ1-5052 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、β-インターフェロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射、局所）、用途別市場規模（病院、診療所、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・β-インターフェロンの市場動向 ・企業の競争状況、市場シェア ・β-インターフェロンの種類別市場規模と予測2016-2027（注射、局所） ・β-インターフェロンの用途別市場規模と予測2016-2027（病院、診療所、ドラッグストア、その他） ・β-インターフェロンの北米市場規模2016-2027（アメリカ、カナダ） ・β-インターフェロンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・β-インターフェロンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・β-インターフェロンの中南米市場規模2016-2027（メキシコ、ブラジル） ・β-インターフェロンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Roche、SP (Brinny) Company、Anke Bio、Sinopharm、Kexing Biopharm、Kawin、Hainan Unipul Pharmaceutical、Tri-Prime Gene、Amoytop Biotech、Changchun Institute of Biological Products） ・結論 |
β-Interferon is a type I interferon. It is produced by various cells such as fibroblasts after induction by viruses and nucleic acids.
Market Analysis and Insights: Global β-Interferon Market
The global β-Interferon market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global β-Interferon market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global β-Interferon market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global β-Interferon market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global β-Interferon market.
Global β-Interferon Scope and Market Size
β-Interferon market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global β-Interferon market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Topical
Segment by Application
Hospital
Clinics
Drug Store
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Roche
SP (Brinny) Company
Anke Bio
Sinopharm
Kexing Biopharm
Kawin
Hainan Unipul Pharmaceutical
Tri-Prime Gene
Amoytop Biotech
Changchun Institute of Biological Products
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global β-Interferon Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Topical
1.3 Market by Application
1.3.1 Global β-Interferon Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global β-Interferon Market Perspective (2016-2027)
2.2 β-Interferon Growth Trends by Regions
2.2.1 β-Interferon Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 β-Interferon Historic Market Share by Regions (2016-2021)
2.2.3 β-Interferon Forecasted Market Size by Regions (2022-2027)
2.3 β-Interferon Industry Dynamic
2.3.1 β-Interferon Market Trends
2.3.2 β-Interferon Market Drivers
2.3.3 β-Interferon Market Challenges
2.3.4 β-Interferon Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top β-Interferon Players by Revenue
3.1.1 Global Top β-Interferon Players by Revenue (2016-2021)
3.1.2 Global β-Interferon Revenue Market Share by Players (2016-2021)
3.2 Global β-Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by β-Interferon Revenue
3.4 Global β-Interferon Market Concentration Ratio
3.4.1 Global β-Interferon Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by β-Interferon Revenue in 2020
3.5 β-Interferon Key Players Head office and Area Served
3.6 Key Players β-Interferon Product Solution and Service
3.7 Date of Enter into β-Interferon Market
3.8 Mergers & Acquisitions, Expansion Plans
4 β-Interferon Breakdown Data by Type
4.1 Global β-Interferon Historic Market Size by Type (2016-2021)
4.2 Global β-Interferon Forecasted Market Size by Type (2022-2027)
5 β-Interferon Breakdown Data by Application
5.1 Global β-Interferon Historic Market Size by Application (2016-2021)
5.2 Global β-Interferon Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America β-Interferon Market Size (2016-2027)
6.2 North America β-Interferon Market Size by Type
6.2.1 North America β-Interferon Market Size by Type (2016-2021)
6.2.2 North America β-Interferon Market Size by Type (2022-2027)
6.2.3 North America β-Interferon Market Size by Type (2016-2027)
6.3 North America β-Interferon Market Size by Application
6.3.1 North America β-Interferon Market Size by Application (2016-2021)
6.3.2 North America β-Interferon Market Size by Application (2022-2027)
6.3.3 North America β-Interferon Market Size by Application (2016-2027)
6.4 North America β-Interferon Market Size by Country
6.4.1 North America β-Interferon Market Size by Country (2016-2021)
6.4.2 North America β-Interferon Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe β-Interferon Market Size (2016-2027)
7.2 Europe β-Interferon Market Size by Type
7.2.1 Europe β-Interferon Market Size by Type (2016-2021)
7.2.2 Europe β-Interferon Market Size by Type (2022-2027)
7.2.3 Europe β-Interferon Market Size by Type (2016-2027)
7.3 Europe β-Interferon Market Size by Application
7.3.1 Europe β-Interferon Market Size by Application (2016-2021)
7.3.2 Europe β-Interferon Market Size by Application (2022-2027)
7.3.3 Europe β-Interferon Market Size by Application (2016-2027)
7.4 Europe β-Interferon Market Size by Country
7.4.1 Europe β-Interferon Market Size by Country (2016-2021)
7.4.2 Europe β-Interferon Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific β-Interferon Market Size (2016-2027)
8.2 Asia-Pacific β-Interferon Market Size by Type
8.2.1 Asia-Pacific β-Interferon Market Size by Type (2016-2021)
8.2.2 Asia-Pacific β-Interferon Market Size by Type (2022-2027)
8.2.3 Asia-Pacific β-Interferon Market Size by Type (2016-2027)
8.3 Asia-Pacific β-Interferon Market Size by Application
8.3.1 Asia-Pacific β-Interferon Market Size by Application (2016-2021)
8.3.2 Asia-Pacific β-Interferon Market Size by Application (2022-2027)
8.3.3 Asia-Pacific β-Interferon Market Size by Application (2016-2027)
8.4 Asia-Pacific β-Interferon Market Size by Region
8.4.1 Asia-Pacific β-Interferon Market Size by Region (2016-2021)
8.4.2 Asia-Pacific β-Interferon Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America β-Interferon Market Size (2016-2027)
9.2 Latin America β-Interferon Market Size by Type
9.2.1 Latin America β-Interferon Market Size by Type (2016-2021)
9.2.2 Latin America β-Interferon Market Size by Type (2022-2027)
9.2.3 Latin America β-Interferon Market Size by Type (2016-2027)
9.3 Latin America β-Interferon Market Size by Application
9.3.1 Latin America β-Interferon Market Size by Application (2016-2021)
9.3.2 Latin America β-Interferon Market Size by Application (2022-2027)
9.3.3 Latin America β-Interferon Market Size by Application (2016-2027)
9.4 Latin America β-Interferon Market Size by Country
9.4.1 Latin America β-Interferon Market Size by Country (2016-2021)
9.4.2 Latin America β-Interferon Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa β-Interferon Market Size (2016-2027)
10.2 Middle East & Africa β-Interferon Market Size by Type
10.2.1 Middle East & Africa β-Interferon Market Size by Type (2016-2021)
10.2.2 Middle East & Africa β-Interferon Market Size by Type (2022-2027)
10.2.3 Middle East & Africa β-Interferon Market Size by Type (2016-2027)
10.3 Middle East & Africa β-Interferon Market Size by Application
10.3.1 Middle East & Africa β-Interferon Market Size by Application (2016-2021)
10.3.2 Middle East & Africa β-Interferon Market Size by Application (2022-2027)
10.3.3 Middle East & Africa β-Interferon Market Size by Application (2016-2027)
10.4 Middle East & Africa β-Interferon Market Size by Country
10.4.1 Middle East & Africa β-Interferon Market Size by Country (2016-2021)
10.4.2 Middle East & Africa β-Interferon Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck β-Interferon Introduction
11.1.4 Merck Revenue in β-Interferon Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche β-Interferon Introduction
11.2.4 Roche Revenue in β-Interferon Business (2016-2021)
11.2.5 Roche Recent Development
11.3 SP (Brinny) Company
11.3.1 SP (Brinny) Company Company Details
11.3.2 SP (Brinny) Company Business Overview
11.3.3 SP (Brinny) Company β-Interferon Introduction
11.3.4 SP (Brinny) Company Revenue in β-Interferon Business (2016-2021)
11.3.5 SP (Brinny) Company Recent Development
11.4 Anke Bio
11.4.1 Anke Bio Company Details
11.4.2 Anke Bio Business Overview
11.4.3 Anke Bio β-Interferon Introduction
11.4.4 Anke Bio Revenue in β-Interferon Business (2016-2021)
11.4.5 Anke Bio Recent Development
11.5 Sinopharm
11.5.1 Sinopharm Company Details
11.5.2 Sinopharm Business Overview
11.5.3 Sinopharm β-Interferon Introduction
11.5.4 Sinopharm Revenue in β-Interferon Business (2016-2021)
11.5.5 Sinopharm Recent Development
11.6 Kexing Biopharm
11.6.1 Kexing Biopharm Company Details
11.6.2 Kexing Biopharm Business Overview
11.6.3 Kexing Biopharm β-Interferon Introduction
11.6.4 Kexing Biopharm Revenue in β-Interferon Business (2016-2021)
11.6.5 Kexing Biopharm Recent Development
11.7 Kawin
11.7.1 Kawin Company Details
11.7.2 Kawin Business Overview
11.7.3 Kawin β-Interferon Introduction
11.7.4 Kawin Revenue in β-Interferon Business (2016-2021)
11.7.5 Kawin Recent Development
11.8 Hainan Unipul Pharmaceutical
11.8.1 Hainan Unipul Pharmaceutical Company Details
11.8.2 Hainan Unipul Pharmaceutical Business Overview
11.8.3 Hainan Unipul Pharmaceutical β-Interferon Introduction
11.8.4 Hainan Unipul Pharmaceutical Revenue in β-Interferon Business (2016-2021)
11.8.5 Hainan Unipul Pharmaceutical Recent Development
11.9 Tri-Prime Gene
11.9.1 Tri-Prime Gene Company Details
11.9.2 Tri-Prime Gene Business Overview
11.9.3 Tri-Prime Gene β-Interferon Introduction
11.9.4 Tri-Prime Gene Revenue in β-Interferon Business (2016-2021)
11.9.5 Tri-Prime Gene Recent Development
11.10 Amoytop Biotech
11.10.1 Amoytop Biotech Company Details
11.10.2 Amoytop Biotech Business Overview
11.10.3 Amoytop Biotech β-Interferon Introduction
11.10.4 Amoytop Biotech Revenue in β-Interferon Business (2016-2021)
11.10.5 Amoytop Biotech Recent Development
11.11 Changchun Institute of Biological Products
11.11.1 Changchun Institute of Biological Products Company Details
11.11.2 Changchun Institute of Biological Products Business Overview
11.11.3 Changchun Institute of Biological Products β-Interferon Introduction
11.11.4 Changchun Institute of Biological Products Revenue in β-Interferon Business (2016-2021)
11.11.5 Changchun Institute of Biological Products Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global β-Interferon Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Topical
Table 4. Global β-Interferon Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global β-Interferon Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global β-Interferon Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global β-Interferon Market Share by Regions (2016-2021)
Table 8. Global β-Interferon Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global β-Interferon Market Share by Regions (2022-2027)
Table 10. β-Interferon Market Trends
Table 11. β-Interferon Market Drivers
Table 12. β-Interferon Market Challenges
Table 13. β-Interferon Market Restraints
Table 14. Global β-Interferon Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global β-Interferon Market Share by Players (2016-2021)
Table 16. Global Top β-Interferon Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in β-Interferon as of 2020)
Table 17. Ranking of Global Top β-Interferon Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by β-Interferon Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players β-Interferon Product Solution and Service
Table 21. Date of Enter into β-Interferon Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 24. Global β-Interferon Revenue Market Share by Type (2016-2021)
Table 25. Global β-Interferon Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global β-Interferon Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global β-Interferon Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global β-Interferon Revenue Market Share by Application (2016-2021)
Table 29. Global β-Interferon Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global β-Interferon Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 32. North America β-Interferon Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America β-Interferon Market Size by Application (2016-2021) (US$ Million)
Table 34. North America β-Interferon Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America β-Interferon Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America β-Interferon Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe β-Interferon Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe β-Interferon Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe β-Interferon Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe β-Interferon Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe β-Interferon Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific β-Interferon Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific β-Interferon Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific β-Interferon Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific β-Interferon Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific β-Interferon Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America β-Interferon Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America β-Interferon Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America β-Interferon Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America β-Interferon Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America β-Interferon Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa β-Interferon Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa β-Interferon Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa β-Interferon Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa β-Interferon Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa β-Interferon Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa β-Interferon Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck β-Interferon Product
Table 64. Merck Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche β-Interferon Product
Table 69. Roche Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. SP (Brinny) Company Company Details
Table 72. SP (Brinny) Company Business Overview
Table 73. SP (Brinny) Company β-Interferon Product
Table 74. SP (Brinny) Company Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 75. SP (Brinny) Company Recent Development
Table 76. Anke Bio Company Details
Table 77. Anke Bio Business Overview
Table 78. Anke Bio β-Interferon Product
Table 79. Anke Bio Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 80. Anke Bio Recent Development
Table 81. Sinopharm Company Details
Table 82. Sinopharm Business Overview
Table 83. Sinopharm β-Interferon Product
Table 84. Sinopharm Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 85. Sinopharm Recent Development
Table 86. Kexing Biopharm Company Details
Table 87. Kexing Biopharm Business Overview
Table 88. Kexing Biopharm β-Interferon Product
Table 89. Kexing Biopharm Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 90. Kexing Biopharm Recent Development
Table 91. Kawin Company Details
Table 92. Kawin Business Overview
Table 93. Kawin β-Interferon Product
Table 94. Kawin Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 95. Kawin Recent Development
Table 96. Hainan Unipul Pharmaceutical Company Details
Table 97. Hainan Unipul Pharmaceutical Business Overview
Table 98. Hainan Unipul Pharmaceutical Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 99. Hainan Unipul Pharmaceutical Recent Development
Table 100. Tri-Prime Gene Company Details
Table 101. Tri-Prime Gene Business Overview
Table 102. Tri-Prime Gene β-Interferon Product
Table 103. Tri-Prime Gene Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 104. Tri-Prime Gene Recent Development
Table 105. Amoytop Biotech Company Details
Table 106. Amoytop Biotech Business Overview
Table 107. Amoytop Biotech β-Interferon Product
Table 108. Amoytop Biotech Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 109. Amoytop Biotech Recent Development
Table 110. Changchun Institute of Biological Products Company Details
Table 111. Changchun Institute of Biological Products Business Overview
Table 112. Changchun Institute of Biological Products β-Interferon Product
Table 113. Changchun Institute of Biological Products Revenue in β-Interferon Business (2016-2021) & (US$ Million)
Table 114. Changchun Institute of Biological Products Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global β-Interferon Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Topical Features
Figure 4. Global β-Interferon Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Drug Store Case Studies
Figure 8. Others Case Studies
Figure 9. β-Interferon Report Years Considered
Figure 10. Global β-Interferon Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global β-Interferon Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global β-Interferon Market Share by Regions: 2020 VS 2027
Figure 13. Global β-Interferon Market Share by Regions (2022-2027)
Figure 14. Global β-Interferon Market Share by Players in 2020
Figure 15. Global Top β-Interferon Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in β-Interferon as of 2020
Figure 16. The Top 10 and 5 Players Market Share by β-Interferon Revenue in 2020
Figure 17. Global β-Interferon Revenue Market Share by Type (2016-2021)
Figure 18. Global β-Interferon Revenue Market Share by Type (2022-2027)
Figure 19. North America β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America β-Interferon Market Share by Type (2016-2027)
Figure 21. North America β-Interferon Market Share by Application (2016-2027)
Figure 22. North America β-Interferon Market Share by Country (2016-2027)
Figure 23. United States β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe β-Interferon Market Share by Type (2016-2027)
Figure 27. Europe β-Interferon Market Share by Application (2016-2027)
Figure 28. Europe β-Interferon Market Share by Country (2016-2027)
Figure 29. Germany β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific β-Interferon Market Share by Type (2016-2027)
Figure 37. Asia-Pacific β-Interferon Market Share by Application (2016-2027)
Figure 38. Asia-Pacific β-Interferon Market Share by Region (2016-2027)
Figure 39. China β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America β-Interferon Market Share by Type (2016-2027)
Figure 47. Latin America β-Interferon Market Share by Application (2016-2027)
Figure 48. Latin America β-Interferon Market Share by Country (2016-2027)
Figure 49. Mexico β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa β-Interferon Market Share by Type (2016-2027)
Figure 53. Middle East & Africa β-Interferon Market Share by Application (2016-2027)
Figure 54. Middle East & Africa β-Interferon Market Share by Country (2016-2027)
Figure 55. Turkey β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE β-Interferon Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 60. SP (Brinny) Company Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 61. Anke Bio Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 62. Sinopharm Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 63. Kexing Biopharm Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 64. Kawin Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 65. Hainan Unipul Pharmaceutical Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 66. Tri-Prime Gene Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 67. Amoytop Biotech Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 68. Changchun Institute of Biological Products Revenue Growth Rate in β-Interferon Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
インターフェロンベータ-1aのグローバル市場調査 2019年 The global Interferon Beta-1a market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Beta-1a volume and value at global level, regional level and company level. From a global perspective, this r…- インターフェロンアルファ-2bバイオシミラーのグローバル市場調査 2019年 The global Interferon Alpha-2b Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Alpha-2b Biosimilar volume and value at global level, regional level and company level. From a gl…
- 世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
- 世界の局所にきび治療市場規模・現状・予測（2021年-2027年） Acne is the most common skin disease and topical treatment can reduce the severity and frequency of acne growth. Market Analysis and Insights: Global Topical Use Acne Treatment Market The global Topical Use Acne Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million …